Sign in

CIK 0001671502 · Non-accelerated filer<br>Smaller reporting company

Quoin Pharmaceuticals Ltd.

Sign in to watch
Ticker
QNRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Incorporated
Israel
Entity type
operating
Phone
703 980 4182
Business address
42127 PLEASANT FOREST COURT, ASHBURN, VA, 20148-7349
Former names
Quoin Pharmaceuticals, Ltd., Cellect Biotechnology Ltd., Cellect Biomed Ltd.
Open-market buys, last 90 days
$279,966
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$279,966. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Carter Denise P. +$100K Chief Operating Officer 1 filing
  2. Myers Michael +$100K Chief Executive Officer 1 filing
  3. Lawlor Sally Bridget +$50K Chief Financial Officer 1 filing
  4. Culverwell Anthony James +$30K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2024-09-09 Dunn Gordon Chief Financial Officer Purchase +4,000 $0.80 $3K 8,856
2024-09-04 Carter Denise P. Chief Operating Officer Purchase +8,825 $0.75 $7K 24,104
2024-09-04 Carter Denise P. Chief Operating Officer Purchase +22,988 $0.80 $18K 47,092
2024-09-04 Myers Michael Chief Executive Officer Purchase +5,322 $0.66 $3K 15,480
2024-09-04 Myers Michael Chief Executive Officer Purchase +8,200 $0.75 $6K 23,680
2024-09-04 Myers Michael Chief Executive Officer Purchase +23,572 $0.80 $19K 47,252
2024-09-03 Carter Denise P. Chief Operating Officer Purchase +1,822 $0.63 $1K 11,179
2024-09-03 Carter Denise P. Chief Operating Officer Purchase +4,100 $0.66 $3K 15,279
2024-09-03 Myers Michael Chief Executive Officer Purchase +800 $0.62 $495 10,158
2024-06-07 LANGER DENNIS Director Sale −297 $0.73 $217 53
2023-10-26 SEMBER MICHAEL T Director Grant or award · Share Option (Right to Buy) +7,652 7,652
2023-10-26 Dunn Gordon Chief Financial Officer Grant or award · Share Option (Right to Buy) +51,149 51,149
2023-10-26 Myers Michael Chief Executive Officer Grant or award · Share Option (Right to Buy) +80,965 80,965
2023-10-26 Culverwell Anthony James Director Grant or award · Share Option (Right to Buy) +7,652 7,652
2023-10-26 Cooper Joseph Patrick Director Grant or award · Share Option (Right to Buy) +7,652 7,652
2023-10-26 Leong Natalie Ee Mun Director Grant or award · Share Option (Right to Buy) +7,652 7,652
2023-10-26 Carter Denise P. Chief Operating Officer Grant or award · Share Option (Right to Buy) +80,966 80,966
2023-10-26 LANGER DENNIS Director Grant or award · Share Option (Right to Buy) +7,652 7,652

Page 4 of 4 · 78 trades